Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme in *Plasmodium falciparum* refers to iron protoporphyrin IX, a cofactor found in numerous essential enzymes, including cytochromes, and a toxic byproduct generated during the digestion of host hemoglobin by blood-stage parasites. Excess free heme is highly reactive and can damage cellular components through oxidative mechanisms. To overcome this, *P. falciparum* detoxifies heme by converting it to hemozoin (malaria pigment) via specialized proteins such as heme detoxification protein (HDP). Antimalarial drugs like chloroquine work by disrupting this detoxification process, resulting in heme accumulation and death of the parasite
Inhibition of heme polymerization (e.g., chloroquine, mefloquine, quinidine block conversion of toxic free heme to inert hemozoin) Formation of heme–drug complexes, leading to toxic heme accumulation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme (Plasmodium falciparum).